Pharmacokinetics, Safety, and Tolerability of Vonoprazan ‐ or Esomeprazole‐Based Bismuth‐Containing Quadruple Therapy: A Phase 1, Double‐Blind, Parallel‐Group Study in Adults with Helicobacter pylori Infection in China
In conclusion, vonoprazan had no significant effect on plasma bismuth exposure compared with esomeprazole.
Source: Clinical Pharmacology in Drug Development - Category: Drugs & Pharmacology Authors: Jia Miao,
Chao Hu,
Jie Tang,
Wenyan Wang,
Ying Wang,
Ruoting Men,
Li Yang,
Liqun Gu,
Naoki Yoshida,
Richard Czerniak Tags: Original Article Source Type: research
More News: Amoxicillin | Biaxin | China Health | Clarithromycin | Drugs & Pharmacology | Esomeprazole | Helicobacter Pylori | Nexium | Potassium | Potassium Citrate | Proton Pump Inhibitors PPIs | Study